Meihua International Regains Nasdaq Compliance, Meets Minimum Bid Price Requirement
Meihua International Regains Nasdaq Compliance, Meets Minimum Bid Price Requirement
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on October 3, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement").
美华国际医疗科技有限公司（"MHUA"或"公司"）(纳斯达克股票代码：MHUA) 是一家享有声誉的一、二、三类一次性医疗设备制造商和提供商，在中国设有运营子公司。今日宣布，于2024年10月3日，该公司收到了纳斯达克股票市场有限责任公司（"纳斯达克"）上市资格部的一封通知信（"通知信"），通知公司已恢复符合纳斯达克上市规则5450(a)(1)中规定的最低买盘价格要求（"最低买盘价格要求"）。
As previously reported, the Company was notified on April 2, 2024, that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Nasdaq Minimum Bid Price Requirement.
正如之前报告的那样，公司于2024年4月2日收到通知，其普通股未能在前30个连续工作日内维持每股$1.00的最低买盘价格，这是纳斯达克最低买盘价格要求的要求。
